Electromed, Inc.

ELMD ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Revenue $14.8M $13.9M $13.7M $12.3M $13.6M $12.1M $11.7M $10.7M
Cost of Revenue $3.5M $3.5M $3.1M $2.8M $3.2M $3.0M $3.0M $2.3M
Gross Profit $11.3M $10.4M $10.5M $9.5M $10.5M $9.1M $8.7M $8.3M
Gross Margin 76.2% 74.8% 77.0% 77.1% 76.8% 75.0% 74.0% 78.2%
Operating Expenses
Research & Development $176.0K $167.0K $107.0K $206.0K $298.0K $166.0K $154.0K $298.0K
SG&A Expense $8.8M $8.4M $8.2M $9.2M $8.7M $7.7M $7.3M $8.0M
Operating Income $2.3M $1.8M $2.3M $142.0K $1.5M $1.2M $1.3M $44.0K
Operating Margin 15.7% 13.3% 16.5% 1.2% 11.0% 9.9% 10.9% 0.4%
Interest Expense — — — — — — — —
Pretax Income $2.5M $2.0M $2.4M $219.0K $1.5M $1.2M $1.3M $48.0K
Income Tax Expense $669.0K $468.0K $685.0K $64.0K $502.0K $147.0K $304.0K $-33.0K
Net Income $1.8M $1.5M $1.7M $155.0K $1.0M $1.1M $977.0K $81.0K
Net Margin 12.3% 10.8% 12.2% 1.3% 7.6% 8.9% 8.3% 0.8%
EPS (Basic) $0.21 $0.17 $0.20 $0.02 $0.11 $0.13 $0.12 $0.01
EPS (Diluted) $0.20 $0.17 $0.19 $0.02 $0.12 $0.12 $0.11 $0.01
Shares Outstanding (Basic) 8.6M 8.6M 8.5M 8.5M 8.5M 8.5M 8.4M 8.4M
Shares Outstanding (Diluted) 8.9M 8.9M 8.8M 8.8M 8.7M 8.7M 8.7M 8.7M
Dividends Per Share — — — — — — — —
← Newer Page 2 of 8 Older →